论文部分内容阅读
目的观察阿司匹林联合奥扎格雷钠治疗急性脑梗死的临床疗效及不良反应。方法将我院60例急性脑梗死患者分为观察组与对照组,对照组患者口服阿司匹林肠溶片进行治疗,观察组患者在此基础上静脉滴注奥扎格雷钠注射液。结果观察组患者治疗总有效率明显高于对照组,差异有统计学意义(P<0.05);两组患者均未见严重不良反应。结论使用阿司匹林联合奥扎格雷钠对急性脑梗死患者进行治疗,可以有效改善患者的神经功能状况,明显提高临床治疗效果,且没有严重不良反应。
Objective To observe the clinical efficacy and adverse reactions of aspirin combined with ozagrel sodium in the treatment of acute cerebral infarction. Methods Sixty patients with acute cerebral infarction in our hospital were divided into observation group and control group. The patients in the control group were treated with aspirin enteric-coated tablets. On the basis of this, patients in the observation group were given intravenous injection of ozagrel sodium. Results The total effective rate of observation group was significantly higher than that of control group, the difference was statistically significant (P <0.05). No serious adverse reactions were observed in both groups. Conclusion Aspirin combined with ozagrel sodium in patients with acute cerebral infarction can effectively improve the patient’s neurological status, significantly improve the clinical effect, and no serious adverse reactions.